Luke Sergott
Stock Analyst at Barclays
(3.38)
# 994
Out of 5,078 analysts
352
Total ratings
49.24%
Success rate
2.58%
Average return
Main Sectors:
Stocks Rated by Luke Sergott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Equal-Weight | $145 → $165 | $150.10 | +9.93% | 13 | Nov 25, 2025 | |
| EXAS Exact Sciences | Downgrades: Equal-Weight | $77 → $105 | $101.20 | +3.75% | 9 | Nov 21, 2025 | |
| TWST Twist Bioscience | Maintains: Overweight | $40 → $37 | $29.86 | +23.91% | 19 | Nov 17, 2025 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,350 → $1,600 | $1,468.09 | +8.99% | 3 | Nov 10, 2025 | |
| NTRA Natera | Maintains: Overweight | $210 → $230 | $234.25 | -1.81% | 5 | Nov 7, 2025 | |
| CERT Certara | Maintains: Overweight | $16 → $14 | $8.85 | +58.19% | 19 | Nov 7, 2025 | |
| TXG 10x Genomics | Maintains: Overweight | $15 → $17 | $18.08 | -5.97% | 14 | Nov 7, 2025 | |
| FTRE Fortrea Holdings | Maintains: Underweight | $8 → $10 | $12.44 | -19.61% | 13 | Nov 6, 2025 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $195 → $210 | $176.09 | +19.26% | 10 | Nov 6, 2025 | |
| SHC Sotera Health Company | Maintains: Overweight | $19 → $20 | $17.35 | +15.27% | 23 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $40 → $45 | $47.86 | -5.98% | 7 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $95 → $100 | $128.72 | -22.31% | 21 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $70 → $85 | $105.22 | -19.22% | 5 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $15 → $12 | $11.75 | +2.13% | 27 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $160 → $175 | $166.35 | +5.20% | 3 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $105 | $102.43 | +2.51% | 11 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $275 → $325 | $274.14 | +18.55% | 4 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $425 → $485 | $587.98 | -17.51% | 4 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $190 → $185 | $179.71 | +2.94% | 22 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $585 → $625 | $585.15 | +6.81% | 29 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $225 → $250 | $224.14 | +11.54% | 41 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $185 → $200 | $228.47 | -12.46% | 24 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $55 → $53 | $47.34 | +11.96% | 2 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $102.04 | -11.80% | 1 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2 → $1.5 | $2.23 | -32.74% | 5 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $400 → $350 | $397.79 | -12.01% | 18 | Apr 10, 2025 |
Agilent Technologies
Nov 25, 2025
Maintains: Equal-Weight
Price Target: $145 → $165
Current: $150.10
Upside: +9.93%
Exact Sciences
Nov 21, 2025
Downgrades: Equal-Weight
Price Target: $77 → $105
Current: $101.20
Upside: +3.75%
Twist Bioscience
Nov 17, 2025
Maintains: Overweight
Price Target: $40 → $37
Current: $29.86
Upside: +23.91%
Mettler-Toledo International
Nov 10, 2025
Maintains: Overweight
Price Target: $1,350 → $1,600
Current: $1,468.09
Upside: +8.99%
Natera
Nov 7, 2025
Maintains: Overweight
Price Target: $210 → $230
Current: $234.25
Upside: -1.81%
Certara
Nov 7, 2025
Maintains: Overweight
Price Target: $16 → $14
Current: $8.85
Upside: +58.19%
10x Genomics
Nov 7, 2025
Maintains: Overweight
Price Target: $15 → $17
Current: $18.08
Upside: -5.97%
Fortrea Holdings
Nov 6, 2025
Maintains: Underweight
Price Target: $8 → $10
Current: $12.44
Upside: -19.61%
Charles River Laboratories International
Nov 6, 2025
Maintains: Overweight
Price Target: $195 → $210
Current: $176.09
Upside: +19.26%
Sotera Health Company
Nov 5, 2025
Maintains: Overweight
Price Target: $19 → $20
Current: $17.35
Upside: +15.27%
Nov 4, 2025
Maintains: Overweight
Price Target: $40 → $45
Current: $47.86
Upside: -5.98%
Oct 31, 2025
Maintains: Underweight
Price Target: $95 → $100
Current: $128.72
Upside: -22.31%
Oct 30, 2025
Maintains: Overweight
Price Target: $70 → $85
Current: $105.22
Upside: -19.22%
Oct 30, 2025
Downgrades: Equal-Weight
Price Target: $15 → $12
Current: $11.75
Upside: +2.13%
Oct 29, 2025
Maintains: Overweight
Price Target: $160 → $175
Current: $166.35
Upside: +5.20%
Oct 28, 2025
Maintains: Overweight
Price Target: $100 → $105
Current: $102.43
Upside: +2.51%
Oct 27, 2025
Maintains: Equal-Weight
Price Target: $275 → $325
Current: $274.14
Upside: +18.55%
Oct 24, 2025
Maintains: Underweight
Price Target: $425 → $485
Current: $587.98
Upside: -17.51%
Oct 24, 2025
Maintains: Equal-Weight
Price Target: $190 → $185
Current: $179.71
Upside: +2.94%
Oct 23, 2025
Maintains: Overweight
Price Target: $585 → $625
Current: $585.15
Upside: +6.81%
Oct 22, 2025
Maintains: Overweight
Price Target: $225 → $250
Current: $224.14
Upside: +11.54%
Oct 2, 2025
Maintains: Equal-Weight
Price Target: $185 → $200
Current: $228.47
Upside: -12.46%
Oct 2, 2025
Maintains: Overweight
Price Target: $55 → $53
Current: $47.34
Upside: +11.96%
Aug 1, 2025
Initiates: Overweight
Price Target: $90
Current: $102.04
Upside: -11.80%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $2 → $1.5
Current: $2.23
Upside: -32.74%
Apr 10, 2025
Maintains: Equal-Weight
Price Target: $400 → $350
Current: $397.79
Upside: -12.01%